PSNL News and Press, Personalis Inc. From 04/21/20

HAMBURG, Germany and MENLO PARK, Calif. , April 21, 2020 /PRNewswire/ -- Indivumed GmbH ("Indivumed") and Personalis, Inc. (Nasdaq: PSNL) today announced that the two companies have entered into a collaboration in the field of personalized oncology. The partnership seeks to enable ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of their Pharma Research Solutions, the latest expansion of the company’s portfolio of comprehensive genomics assays and analytics. These solutions, which leverage Personalis’ p...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate in the 1-on-1 meetings at the upcoming 19th Annual Needham Virtual Healthcare Conference from Tuesday, April 14, 2020 through Wednesday, April 15, 2020. Abo...

Personalis ( PSNL ) has triggered my interest since it has gone public in the summer of 2019. With PSNL reporting its full-year results in the middle of the Corona crisis, it is time to update my stance on the company. Fourth-quarter results were more or less in line with expectations, and d...

Image source: The Motley Fool. Personalis, Inc.   (NASDAQ: PSNL) Q4 2019 Earnings Call Mar 25, 2020 , 5:00 p.m. ET Operator Continue reading

Personalis, Inc. (PSNL) Q4 2019 Earnings Conference Call March 25, 2020 5:00 p.m. ET Company Participants Caroline Corner - Westwicke ICR John West - President and CEO Aaron Tachibana - CFO Clinton Musil - Chief Business Officer Conference Call Participants Derik De Bruin...

Personalis (NASDAQ: PSNL ): Q4 GAAP EPS of -$0.21 beats by $0.06 . More news on: Personalis, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today reported financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter and Full Year 2019 Highlights Reported record revenues of $18.2 million in the fourth quarter an...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced it will release its fourth quarter and full year 2019 financial results after the market closes on Wednesday, March 25, 2020. In conjunction with the release, the Company will host a conference call and...